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1. Introduction
One of the crucial steps in designing subunit vaccine for 
diseases like cancer involves identifi cation of antigenic 
peptides that can stimulate cytotoxic T lymphocytes (CTLs). 
The binding of antigenic peptide to MHC class I molecule 
is a prerequisite for their recognition by CTLs (Cresswell
et al 1999). Determination of binding specifi city of peptides 
derived from a protein to MHC class I molecules requires the 
binding assay of hundreds of multiple overlapping peptides 
spanning the whole protein. This is a very laborious and 
time-consuming task. The utility of computational methods 
to screen the initial hundreds of peptides and to determine 
the probable candidate peptides for further experiments 
has been successfully tested in the past (Vordermeier et al 
2003). 
A number of methods have been developed for 
predicting MHC binders in an antigen sequence on the 
basis of rules that govern the binding of a peptide to MHC 
molecule. Most of these methods are knowledge-based 
where experimentally identifi ed binders are used to derive 
the rules. These methods can be broadly classifi ed in to 
four categories; (i) methods based on binding motif; (ii) 
quantitative matrix based methods; (iii) machine learning 
techniques and (iv) ab initio or structure based methods. In 
binding motifs-based algorithms, the binding of peptides to 
A hybrid approach for predicting promiscuous MHC class I restricted
T cell epitopes
MANOJ BHASIN and G P S RAGHAVA*
Institute of Microbial Technology, Sector 39A, Chandigarh 160 036, India
*Corresponding author (Fax, 91-172-690632; Email: raghava@imtech.res.in)
In the present study, a systematic attempt has been made to develop an accurate method for predicting MHC class 
I restricted T cell epitopes for a large number of MHC class I alleles. Initially, a quantitative matrix (QM)-based 
method was developed for 47 MHC class I alleles having at least 15 binders. A secondary artifi cial neural network 
(ANN)-based method was developed for 30 out of 47 MHC alleles having a minimum of 40 binders. Combination of 
these ANN- and QM-based prediction methods for 30 alleles improved the accuracy of prediction by 6% compared 
to each individual method.  Average accuracy of hybrid method for 30 MHC alleles is 92.8%. This method also 
allows prediction of binders for 20 additional alleles using QM that has been reported in the literature, thus allowing 
prediction for 67 MHC class I alleles. The performance of the method was evaluated using jack-knife validation 
test. The performance of the methods was also evaluated on blind or independent data. Comparison of our method 
with existing MHC binder prediction methods for alleles studied by both methods shows that our method is superior
to other existing methods. This method also identifi es proteasomal cleavage sites in antigen sequences by implementing 
the matrices described earlier. Thus, the method that we discover allows the identifi cation of MHC class I binders 
(peptides binding with many MHC alleles) having proteasomal cleavage site at C-terminus. The user-friendly result 
display format (HTML-II) can assist in locating the promiscuous MHC binding regions from antigen sequence. 
The method is available on the web at www.imtech.res.in/raghava/nhlapred and its mirror site is available at http:
//bioinformatics.uams.edu/mirror/nhlapred/.
[Bhasin M and Raghava G P S 2006 A hybrid approach for predicting promiscuous MHC class I restricted T cell epitopes; J. Biosci. 32 31–42]
Keywords. Artifi cial neural network; MHC class I alleles; promiscuous binders; proteasomal cleavage site; quantitative matrices.
http://www.ias.ac.in/jbiosci J. Biosci. 32(1), January 2007, 31–42, © Indian Academy of Sciences    31
Abbreviations used: ANN, Artifi cial neural network; CTL, cytotoxic T lymphocytes; QM, quantitative matrix; SSE, Sum of Squared Error 
function.
Manoj Bhasin and G P S Raghava32
J. Biosci. 32(1), January 2007
an allele is examined on the basis of occurrence of specifi c 
residues (anchor residues) at specifi c positions (anchor 
positions) (Rammensee et al 1999). The presence of motifs 
determines whether a peptide will bind to a specifi c allele 
or not. The methods based on motifs have low accuracy of 
prediction because all the peptides binding with MHC do not 
have exact motifs (Buus 1999). 
In order to overcome the limitations of motif-based 
approach, quantitative/profi le matrix based methods have 
been developed (Parker et al 1994; Singh and Raghava 2001). 
The quantitative matrix (QM)-based methods consider 
the contribution of each residue of a peptide rather than 
just anchor positions/residues. The matrix-based methods 
predict MHC binding peptides with fair accuracy. One major 
limitation of the quantitative matrix based methods is its 
inability to handle the non-linearity in the data. The machine 
learning techniques can handle the non-linearity in data in 
a facile way. Such techniques like artifi cial neural networks 
(ANNs) have been previously applied for the prediction of 
MHC binders (Adams and Koziol 1995). The ANN correctly 
classifi ed the peptides as binders or non-binders in 78% 
of cases for HLA-A2 and 88% of cases for H-2Kb MHC 
alleles (Brusic et al 1994). ANN was also able to correctly 
predict 78% of binders for HLA-A*0201 (Adams and 
Koziol 1995). The ANN-based method predicts fewer false 
positive binders in comparison to motifs based algorithms 
(Gulukota et al 1997). Thus, It is more reliable in classifying 
the non-linear data of MHC binders and non-binders in 
comparison to algorithms based on quantitative matrix and 
motifs-based. The major constraint in ANN-based methods 
is that they requires large dataset for training. In case of ab 
initio methods, prediction is based on structural binding 
of MHC molecule and peptides (Schueler-Furman et al 
2000; Doytchinova and Flower 2001). There are two major 
limitations of ab initio-based methods: (i) they are very
slow and (ii) not possible to develop method for most of 
the MHC alleles due to unavailability of three-dimensional 
structural data of these alleles. The high proportion of false 
positive binders in prediction is another limitation of these 
methods.
The existing methods have two major drawbacks. First, 
most of the existing methods have been developed for one 
or two most common MHC alleles (Brusic et al 1994;Adams 
and Koziol 1995; Honeyman et al 1998). These methods are 
not suitable for identifi cation of potential vaccine candidates, 
because an ideal candidate should have the capability to 
bind with many MHC alleles. The peptides binding with 
variety of MHC alleles are known as promiscuous MHC 
binders (Hammer et al 1993; Sturniolo et al 1999; Singh and 
Raghava 2003). In past, attempts have been made to address 
this problem by developing methods for prediction for 
large number of alleles, for example Tepitope and ProPred 
for MHC class II and ProPred1 for MHC class I (Hammer
et al 1993; Sturniolo et al 1999; Singh and Raghava 2001, 
2003). Secondly, these methods have been developed 
using information from a limited number of binders and 
non-binders. There is continuous increase in data of MHC 
binders and non-binders over the years, thus there is a need 
to develop methods using large and clean dataset (Bhasin et 
al 2003). This is because the performance of knowledge-
based methods is directly proportional to size and quality of 
data used for their development/training. 
In order to overcome some of the aforesaid limitations 
and to complement existing methods, in this study, we have 
developed hybrid method for a large numbers of MHC class 
I alleles. Firstly, we have developed a QM based method for 
47 alleles for which minimum 15 binders were available. The 
binders were obtained from MHCBN version 1.1 (Bhasin
et al 2002). Secondly, ANN-based method was developed 
for 30 alleles out of these 47 alleles had at least 40 binders 
available in database. Finally, a hybrid method was 
developed for these 30 MHC class I alleles by combining 
ANN- and QM-based methods in order to improve the 
performance. One of the goals of this study is to develop a 
method for large number of MHC alleles. Therefore, we also 
developed quantitative matrix based method for 20 more 
alleles for which quantitative matrices were obtained from 
literature (Singh and Raghava 2003).
In the recent studies, it has been shown that MHC 
binding peptides having proteasomal cleavage site at their 
C terminus have more chances of being recognized by CTL 
cells (Kessler et al 2001; Ayyoub et al 2002; Goldberg et al 
2002). The simultaneous identifi cation of MHC binding and 
proteasomal cleavage sites leads to prediction of potential 
CTL epitopes. Thus, we have implemented the matrices 
described by Toes et al (2001) for the identifi cation of 
MHC binders having proteasome (standard/constitutive 
proteasome and immunoproteasome) cleavage site at their C 
terminal (Toes et al 2001). The overall structure of prediction 
method is shown in fi gure 1.
In summary, our method allows prediction of binding 
peptides for 67 MHC class I alleles (30 alleles based on 
hybrid approach, 17 based on new QM and 20 based on 
old QM). The performance of the prediction method was 
compared with previously published methods – SYFPEITHI 
(Rammensee et al 1999), BIMAS (Parker et al 1994)
and SVMHC (Donnes and Elofsson 2002). For alleles 
like HLA-A*0201 and HLA-A2.1, our method was also 
compared with RANKPEP (Reche et al 2002), PREDEP 
(Schueler-Furman et al 2000) and polynomial (Gulukota et al 
1997) methods. The results demonstrated that performance 
of our method is better as compared to existing MHC binders 
prediction algorithms. This method has been implemented 
online as nHLAPred at http://www.imtech.res.in/raghava/
nhlapred to assist in identifying promiscuous MHC class I 
restricted CTL epitopes.
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2. Materials and methods
2.1 Datasets of MHC binders and non-binders
MHC binders for 47 MHC class I alleles having atleast 
15 binders were obtained from MHCBN database (Bhasin
et al 2003). Equal number of non-binders for these alleles 
were also obtained from MHCBN. In case equal number of 
non-binders at MHCBN are not available than remaining 
were generated from the SWISS-PROT database (Bairoch 
and Apweiler 2000) by randomly choosing peptides of 9 
amino acids. Complete dataset of each MHC allele has 
nearly equal number of MHC binders and non-binders. 
The ratio of binders and non-binders was kept 1:1 for 
developing and evaluating the performance of the method 
by a single parameter like accuracy at a cutoff score where 
the sensitivity and specifi city are nearly equal. 
2.2 Blind datasets
The performance of method for few alleles was also 
evaluated on blind or independent datasets. The blind 
dataset was generated for each MHC allele. The binders 
for each allele were obtained from the published literature 
(for detail visit http://www.imtech.res.in/raghava/nhalpred/
supl/). Equal number of non-binders for each allele were 
obtained either from MHCBN database (wherever available) 
or generated randomly from proteins of SWISS-PROT 
database. All the binders and non-binders which were used 
for testing and training of this method were removed from 
these blind datasets. 
2.3 Methods
2.3a Generation of quantitative matrices: The quantitative 
matrices were generated for 47 MHC class I alleles. The 
coeffi cient value of each amino acid from position 1 to 
9 was obtained by dividing the probability of an amino 
acid at specifi c position in binders and in non-binders. 
It is prerequisite to calculate the cutoff/threshold score 
for each of the matrices. Due to lack of suffi cient data, 
it was not possible to compute the threshold score using 
standard methods. So, we have followed the strategy 
adopted in ProPred, a method for prediction of MHC class 
I restricted T cell epitopes  (Singh and Raghava 2001). In 
brief, the threshold score of a matrix was determined using 
following steps. First all overlapping peptides of 9 amino 
acids were generated from all the proteins of SWISS-PROT 
database. The score of these peptides were obtained by 
using quantitative matrix. The peptides were sorted in the 
descending order and top 1% of the peptides was extracted. 
Minimum score out of these peptides was considered as 
threshold score at 1%. Similarly, the threshold score at 2%, 
3% etc. were calculated. The quantitative matrices generated 
above are addition matrices where peptide score is calculated 
by summing up the scores of each residue at specifi c position 
along the peptide sequence. 
Creation of datasets
  [47 MHC alleles]
QM generation &
   ANN Training
  MHC binders prediction
using ANNPred & ComPred
Potential CTL epitopes
        prediction
MHC binders (9 mers)
from MHCBN
Datasets
MHC non-binders from
MHCBN or SWISS-PROT
Training & testing of
ANN for 30 alleles
      (LOOCV)
Generation of QM for
    47 MHC alleles.
Testing through LOOCV
     Matrices of 20
additional MHC alleles
obtained from BIMAS
ANNPRED
ComPred
MHC binders prediction by using ANN
    (User can specify cutoff score)
Prediction using hybrid
approach (ANN and QM)
for 30 common alleles
QM based method for 37 alleles


17 new QM
20 QM from BIMAS
Prediction of proteasomal
(immuno + standard)
cleavage sites in query
sequence
Predicted MHC
binders
Potential CTL epitopes
  [MHC binders having
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at carboxyl terminal]
Figure 1. The overall structure of nHLAPred which have four major parts: (i) creation of datasets, (ii) QM generation and ANN training, 
(iii) MHC binders prediction using ANN and ComPred and (iv) potential CTL epitopes prediction which involve prediction of proteasomal 
cleavage sites as well as identifi cation of MHC binders having cleavage site at C terminus.
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2.3b Artifi cial neural network: ANN-based method was 
developed for 30 out of 47 alleles had at least 40 MHC binders. 
ANN implementation was achieved by using Stuttgart 
Neural Network Simulator, SNNS 4.2 (Hertz et al 1991; 
Zell A and Mamier G: Stuttgart Neural Network Simulator, 
version 4.2, University of Stuttgart). A feed-forward neural 
network with standard backpropagation algorithm having 
single hidden layer (10 hidden units), 189 (21×9) input units 
and 1 output unit was used. The input layer consisted of 189 
nodes to represent peptide of nine amino acids. Amino acids 
were represented as binary strings of length 21 (we used X 
in addition to natural amino acids, to represent termini and 
unknown amino acids). The linear activation function and 
random weights were used to initialize ANN training. The 
training was carried out using standard back propagation 
with a Sum of Squared Error function (SSE). The magnitude 
of the SSE on training and testing set was monitored after 
each cycle. The ultimate number of cycles was determined 
when the network converges.
2.3c Hybrid method: Combination of ANN and QM: A 
hybrid method was developed by combining QM- and 
ANN-based methods in order to improve the accuracy of 
prediction. The ANN predicted binders and non-binders 
were reexamined using QM-based method. If any of ANN 
predicted binder had very poor score for QM (lower than 
cutoff score at 10%) then it was assigned non-binder in 
fi nal prediction. Similarly, if any ANN predicted non-
binder achieved very high score for QM (greater than cutoff
score at 1%) then it was considered binder in fi nal prediction. 
In this manner, hybrid method utilized the positive qualities 
of both ANN- and QM-based approaches for better 
prediction.
2.3d Jack-knife testing: Jack-knife testing is a well-
accepted technique to evaluate the performance of a method
(Mardia et al 1979; Yuan 1999; Feng 2001; Feng and Zhang 
2001; Hua and Sun 2001). Jack-knife validation test was used 
to evaluate the performance of all the methods developed in 
this study. In jack-knife validation test, one peptide was used 
for testing and rest of the peptides were used for training. 
This procedure was repeated N times (N is total number of 
peptides in dataset), so that each peptide was used only once 
for testing. The performance of the method was obtained by 
averaging the performance over N test sets.
2.3e Prediction of proteasome cleavage site: For 
prediction of proteasomal cleavage sites the proteasomal 
and immunoproteasomal matrices were obtained from the 
ProPred I server, derived from the work of Toes et al (2001) 
(Singh and Raghava 2001). The proteasomal cleavage 
site occurs at the center of 12mer peptides that is six
amino acid away from N-terminal. The prediction of 
proteasomal cleavage site in antigenic proteins was achieved 
as follows. First overlapping peptides of 12 amino acids 
were obtained from the antigenic protein. Then score of 
each peptide was calculated by using proteasomal and/or 
immunoproteasomal matrices. The peptides with score 
more than cutoff score at selected threshold were predicted 
as peptides with proteasomal cleavage sites at their center 
position, i.e. six positions away from the amino terminal 
position. 
2.3f Parameters used for assessing the performance: The 
performance of the method was evaluated by comparing 
the prediction results with the experimental fi ndings. The 
standard parameters (sensitivity, specifi city and accuracy) 
and PPV were used for measuring the performance of the 
methods. The PPV measures the probability that a predicted 
binder is in fact a binder. These parameters were computed 
by following equations:
where TP and TN are true predicted binders and non-binders 
respectively. FP and FN are false predicted binders and non-
binders respectively.
3. Results
3.1 Performance of QM-based method
The performance of all 47 QM generated in this study 
was evaluated by using jack-knife validation test. These 
quantitative matrices are available at http://www.imtech.
res.in/raghava/nhlapred/matrix.html. The number of binders 
and non-binders used to derive these quantitative matrices 
are shown in the table S1 of supplementary material (http: 
//www.imtech.res.in/raghava/nhlapred/help.html). Table 1 
demonstrates the performance of QM in terms of sensitivity, 
specifi city, PPV and accuracy at default threshold. 
Performance was measured at default threshold of 5% 
where sensitivity and specifi city were nearly the same for 
most of the alleles. The accuracy of various alleles ranged 
from 63% to 100% and average accuracy for 47 alleles was 
85.4±8.9%. 
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Table 1. The performance of QM-based prediction method for 47 alleles. The performance was measured at default threshold of 5%. 
Allele Name Sensitivity Specifi city PPV Accuracy
HLA-A1 84.09 97.7 97.3 90.9
HLA-A2 69.5 98.4 97.8 83.9
HLA-A*0201 79.74 92.75 91.68 86.24
HLA-A*0202 77.3 97.33 96.6 87.3
HLA-A*0203 68.8 98.3 97.6 83.6
HLA-A*0204 55.2 100 100 77.3
HLA-A*0205 60.8 90.9 87.5 75.5
HLA-A*0206 67.95 92.31 89.83 80.13
HLA-A2.1 81.8 82.2 81.8 82
HLA-A3 64.6 94.7 92.4 79.7
HLA-A*0301 48.8 96.7 94.1 72.7
HLA-A11 76.4 97.6 97 87.2
HLA-A*1101 76.6 98.7 98.3 87.6
HLA-A24 57.89 94.44 91.67 75.68
HLA-A*2402 87.18 98.29 98.08 92.74
HLA-A31 71.1 93.3 91.4 82.2
HLA-A*3301 35.2 93.5 85.7 63.08
HLA-A*6801 81.9 96.7 96.1 89.3
HLA-A*6802 32.5 96.3 93.3 57.1
HLA-B7 90.7 89.3 89.6 90
HLA-B*0702 91.6 94.4 94.2 93
HLA-B8 83.33 93.3 92.5 88.3
HLA-B14 87.2 91.4 91.1 89.3
HLA-B27 96.8 94 92.3 95.2
HLA-B*2703 84.3 100 100 92.1
HLA-B*2704 76.4 100 100 87.5
HLA-B*2705 92.5 96.3 96.1 94.4
HLA-B*2706 39.13 100 100 69.5
HLA-B*2902 90 100 100 94.8
HLA-B35 50 82.8 75 66.2
HLA-B*3501 90.3 89 89.1 89.6
HLA-B44 83.3 100 100 91.3
HLA-B51 64.3 96.5 94.9 80.4
HLA-B*5101 87.2 97.8 97.6 92.5
HLA-B*5102 81.2 95.8 96.3 87.5
HLA-B*5103 73.3 95.8 95.6 83.3
HLA-B*5301 84.2 98.2 97.9 91.2
HLA-B*5401 92.98 96.49 96.36 94.74
H-2Kb 80.43 96.74 96.1 88.59
H-2Kd 64.21 95.79 93.85 80
H-2Db 91.1 84 85.1 87.6
H-2Ld 96.1 92.3 91.3 94
H-2Dd 78.12 96.88 96.15 87.5
H-2Qa 100 100 100 100
HLA-Cw*0401 94.12 100 100 96.7
Mamu-A*04 82.14 92.59 92 87.27
HLA-G 88.8 88.8 88.8 88.8
Mean±STDEV 76.4±16.4 95±4.45 94.0±5.25 85.4±8.9
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3.2 Pformance of ANN method
The ANN learning rate and number of epochs were 
optimized by spending hours of computational power. 
Learning parameter was set to 0.01. The training of ANN 
was optimized to 2000 epochs when there was no further 
reduction in the error compared to previous cycles. We 
observed that the performance of ANN-based methods 
depends on the size of dataset used for training. In order to 
demonstrate the correlation between size and performance, 
we computed the accuracy of ANN method trained on 
various fractions (5%, 10%, 25%, 50%, 75%, 100%) of 
original dataset. The original dataset is consist of 117 
binders and equal number of non-binders for HLA-A*2402 
allele. As sown in fi gure 2, the performance of methods is 
directly proportional to the dataset used for development. 
The detailed performance of methods trained on various 
fractions of datasets is shown in table S2 of supplementary 
material (http://www.imtech.res.in/raghava/nhlapred/supl/
index.html). A good correlation (0.85) was observed between 
the prediction accuracy and number of peptides used for 
training/testing. Thus, we developed the ANN-based method 
only for those 30 MHC alleles having more than 40 MHC 
binders. The performance of the methods was assessed using 
jack-knife testing. The performance of ANN for 30 alleles at 
a default cut off score 0.5 (where sensitivity and specifi city 
are nearly equal) is shown in table 2. The accuracy of the 
prediction varied from 67 % to 96% for various MHC alleles 
with average accuracy of 87.3±5.9. These results support the 
fact that ANN is superior in classifying the MHC binders and 
non-binders.
3.3 Combination of QM and ANN
As demonstrated in table 3, the accuracy of ANN-based 
prediction is higher than QM based prediction for a number 
of alleles and reverse is also true for other alleles (means 
accuracy of QM is better than ANN). We developed hybrid 
method by combining ANN and QM based methods for 
alleles, which are common in both the methods. How to 
combine two methods is an important issue in developing 
hybrid method, in order to utilize their full potential. It 
is possible that hybrid method may perform poorer than 
individual method. In this study ANN is used as base method 
at default cutoff 0.5 for prediction and QM was used for re-
examining these predicted binders and non-binders. The 
prediction was changed in case where QM predicted them 
as different from ANN with very high confi dence (see § 2). 
The prediction results for 30 alleles using hybrid approach 
are shown in the table 3. These results clearly demonstrate 
that hybrid approach based method classifi ed data ~7% and 
~5% more accurately in comparison with individual QM- 
and ANN-based methods respectively.
3.3a Performance on blind/independent datasets: The 
performance of method for few alleles was also evaluated on 
blind datasets. The performance of the prediction method on 
blind dataset will be unbiased because these datasets do not 
contain any binder or non-binder used in the development of 
method. The performance of the hybrid method of different 
alleles on blind is shown in table 4. The performance was 
measured at default threshold (0.5). The performance of the 
most of alleles on blind dataset is similar to performance 
observed during jack-knife validation test. The accuracies 
of the alleles on bind data vary from 76% to 95%. These 
results demonstrate that method developed in this study is 
generalized, not biased to dataset used in training. So, it 
is worth to use this method for prediction of MHC class I 
restricted binders.
3.4 Comparison with existing methods
In order to evaluate comparative performance of the new 
method, we compare its performance with performance of 
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Figure 2. The correlation between the performances of ANN-
based method and size of datasets used for training. The results 
shown are obtained by using various fractions of data (5%, 10%, 
25%, 50%, 75% and 100%). The original dataset have 117 binder 
and equal number of non-binders.
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existing methods like (i) SYFPEITHI (Rammensee et al 
1999), (ii) BIMAS (Parker et al 1994), and (iii) SVMHC 
(Donnes and Elofsson 2002). The performance of BIMAS 
matrices for 20 MHC alleles (present in both BIMAS and 
nHLAPred) was tested on the dataset used in this study. 
The table 5a clearly illustrates that the average accuracy of 
BIMAS matrices (79.6%) was lower than ANN (88.3%), 
QM (88.1%) and the hybrid approach (93.6%) developed 
in this study. To analyse the predictive power of hybrid 
approach, we have also developed a hybrid method by 
combining the BIMAS matrices and ANN methods for 
these 20 MHC alleles. It was interesting to note that even 
combination of old matrices and ANN outperformed any 
individual method. This demonstrated that QM and ANN 
based methods complement each other. The performance 
of nHLAPred was also compared with SYFPEITHI for 10 
MHC alleles (common in nHLAPred and SYFPEITHI). The 
accuracy of SYFPEITHI matrices was considered at a cutoff 
score where sensitivity and specifi city were nearly equal. 
As shown in table 5b the average accuracy of nHLAPred 
(93.9%) was nearly 8% higher than accuracy of SYFPEITHI 
(85.9%). The nHLAPred was also compared with SVMHC, 
MHC Allele Sensitivity Specifi city PPV Accuracy
HLA-A1 95.4 95.4 95.4 95.4
HLA-A2 83.0 88.5 64.9 87.5
HLA-A*0201 83.6 86.1 79.9 85.3
HLA-A*0202 87.3 84.5 84.9 85.9
HLA-A*0203 81.9 81.9 81.9 81.9
HLA-A*0206 84.9 85.8 85.7 85.2
HLA-A2.1 77.2 77.7 77.2 77.5
HLA-A3 83.4 81.2 81.6 82.3
HLA-A*0301 86.3 89.3 89.0 87.7
HLA-A11 88.3 88.3 88.3 88.3
HLA-A*1101 88.3 87.0 87.1 87.6
HLA-A*2402 90.6 91.9 91.8 91.2
HLA-A31 84.4 84.4 84.4 84.4
HLA-A*6801 88.5 85.2 85.7 86.8
HLA-A*6802 67.9 66.6 76.6 67.1
HLA-B7 88.1 86.6 87.0 87.4
HLA-B*0702 97.2 95.2 95.8 96.5
HLA-B8 90.0 88.3 89.3 89.1
HLA-B14 89.3 91.4 91.3 90.4
HLA-B27 96.2 96.8 96.7 96.5
HLA-B*2705 88.8 89.8 89.7 89.3
HLA-B*3501 86.7 86.1 86.2 86.4
HLA-B51 88.5 86.2 86.5 87.3
HLA-B*5101 87.2 85.1 85.4 86.1
HLA-B*5301 94.8 94.8 94.8 94.8
HLA-B*5401 94.7 94.7 94.7 94.7
H-2Kb 82.6 82.6 82.6 82.6
H-2Kd 89.4 90.5 90.4 90
H-2Db 84.9 84.9 84.9 84.9
H-2Ld 91.0 92.3 91.0 91.7
Mean  ±STDEV 87.3±5.8 87.3±6.0 86.6±6.6 87.3±5.9
Table 2.  The performance of ANN-based method for 30 MHC class I alleles at default cutoff score of 0.5.
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Table 3. The performance of hybrid approach for different MHC alleles. The performance is shown at the cutoff score (0.5)
where sensitivity and specifi city are nearly equal.
MHC Allele Sensitivity Specifi city PPV Accuracy
HLA-A1 98.8 96.5 96.6 97.7
HLA-A2 82.2 92.7 79.3 90.8
HLA-A*0201 83.1 92.9 88.6 89.0
HLA-A*0202 87.3 97.1 96.8 92.2
HLA-A*0203 83.6 100 100 91.8
HLA-A*0206 83.3 96.1 95.5 89.7
HLA-A2.1 97.2 91.1 91.4 94.3
HLA-A3 83.4 93.9 93.2 88.7
HLA-A*0301 74.2 98.4 98.0 86.3
HLA-A11 91.1 96.5 96.3 94.1
HLA-A*1101 89.6 98.7 98.7 94.1
HLA-A*2402 94.8 98.2 98.2 96.5
HLA-A31 88.8 100 100 94.4
HLA-A*6801 95.0 96.7 96.6 95.9
HLA-A*6802 55.8 100 100 72.8
HLA-B7 96.0 89.3 90.1 92.7
HLA-B*0702 98.6 98.6 98.6 98.6
HLA-B8 88.3 95 94.6 91.6
HLA-B14 91.4 93.6 93.4 92.5
HLA-B27 98.4 96.8 95.8 97.4
HLA-B*2705 94.4 97.2 97.1 95.8
HLA-B*3501 95.4 90.3 90.7 92.9
HLA-B51 88.5 98.8 98.7 93.6
HLA-B*5101 91.4 97.8 97.7 94.6
HLA-B*5301 98.2 93.1 93.4 95.6
HLA-B*5401 98.2 98.2 98.2 98.2
H-2Kb 84.7 96.7 96.2 90.7
H-2Kd 91.5 100 100 95.7
H-2Db 92.0 88.4 88.8 90.2
H-2Ld 94.8 96.7 96.1 95.8
Mean±SD 91.8±5.4 94.9±3.45 94.0±4.9 93.6±2.92
a support vector machine (SVM) based method (Donnes 
and Elofsson 2002), for 19 alleles in terms of Matthews 
Correlation Coeffi cient (MCC). The fi gure 3a clearly 
demonstrates that the performance of our method was better 
than SVMHC for most of the MHC alleles.
The performance of RANKPEP and PREDEP for the 
most commonly used MHC alleles, HLA-A*0201 allele was 
also evaluated on our dataset. Similarly, we also evaluated 
performance of polynomial matrix described by Gulukota
et al (1997) for HLA-A2.1 allele on our dataset. The 
performance of these algorithms is illustrated in fi gure 3. 
The fi gures 3b,c illustrate that our method performs better in 
comparison to above discussed methods. 
It has to be noted that all the methods compared above 
(except nHLAPred) were evaluated on our dataset without 
cross validation. It is possible that these methods have used 
some of the peptides in our dataset, for their training. Their 
performance will decrease if tested using standard cross 
validation procedure. Authors were unable to check some of 
the previously developed methods, as these are not available 
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Table 4.  The performance of different alleles on blind or independent dataset. The binders of blind dataset are obtained from literature. 
The list of binders of blind dataset along with their bibliographic information is provided in supplementary information at http://
www.imtech.res.in/raghava/nhlapred/supl/index.html.
Allele Dataset (B+N) Sensitivity Specifi city PPV Accuracy
HLA-A*0201 216 86.1 95.4 94.9 90.7
HLA-A2 204 63.7 95.1 92.1 79.4
HLA-A3 98 79.6 93.9 92.9 86.7
H-2Db 48 95.8 95.8 95.8 95.8
HLA-B7 102 78.4 94.1 93.0 86.3
HLA-A*0203 40 80 85 84.2 82.5
HLA-A*0301 46 56.5 95.6 92.8 76.0
Table 5a. The performance individual methods (QM, ANN and BIMAS QM)  and combination of ANN with QM and BIMAS QM-based 
methods for 20 common alleles. 
Name ANN QM (at default threshold) ANN + QM Only BIMAS QM ANN +BIMAS QM
Sensitivity 88.2±4.9 82.6±10.0 91.8±5.4 60.7±16.0 91.3±5.0
Specifi city 88.2±4.8 93.7±4.6 94.9±3.4 96.9±2.7 88.2±6.0
PPV 86.7±7.3 93.2±4.4 94.0±4.9 95.2±4.4 87.4±7.2
NPV 89.1±4.9 85.0±7.1 93.2±4.1 72.3±8.7 92.0±5.1
Accuracy 88.3±4.8 88.1±4.8 93.6±2.9 79.6±8.4 90.0±4.6
Table 5b. Comparison of accuracy of the hybrid approach with 
already existing SYFPEITHI prediction methods. The accuracy is 
compared at a cutoff score where the sensitivity and specifi city are 
nearly equal.
MHC alleles Accuracy
 nHLAPred     SYFPEITHI
H2.Db 90.2 87.6
H2-Kb 90.7 87.6
H2-Kd 95.7 85.2
H2-Ld 95.8 86.9
HLA-A1 97.7 94.8
HLA-A*03 88.7 86.3
HLA-B*0702 98.6 63.8
HLA-B*08 91.6 82.5
HLA-B*2705 95.8 90.2
HLA-B*5101 94.6 93.6
Mean± STDEV 93.9±3.4 85.9±8.6
to public as software/web-server (Brusic et al 1994; Adams 
and Koziol 1995). However, the accuracy reported by these 
methods was lower than our method. In conclusion, a hybrid 
approach based method developed in this study, is a highly 
accurate method for prediction of MHC class I binding 
peptides.
3.5 Prediction of potential CTL epitopes
We combined the prediction of MHC class I binders with 
the information on proteasomal cleavage sites, for effi cient 
prediction of potential T cell epitopes. The prediction of 
proteasomal and immunoproteasome cleavage sites was 
achieved by implementing the matrices of Toes et al (2001). 
Customizing the threshold values could vary the stringency 
of proteasomal prediction. The lower the value of threshold 
the more stringent will be the prediction. The performance 
of this hybrid approach based method in prediction of MHC 
binders and potential T cell epitopes is shown through the 
following case study.
3.5a MHC binders: The method was tested on recently 
published data. The binders of HLA-A*0201 allele in 
a tumour associated antigenic protein PRAME, were 
predicted using hybrid method. These predicted binders 
were compared with experimentally determined binders 
for same allele. The hybrid method classifi ed correctly 73% 
high affi nity and 81% intermediate affi nity binders as shown 
in table 3S (http://www.imtech.res.in/raghava/nhlapred/
supl/) of supplementary material. This has further affi rmed 
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Figure 3. (a) The plot represents the performance of an SVM-
based method SVMHC with hybrid approach-based method 
nHLAPred for 19 MHC alleles, which are present in both methods. 
The comparison was done in term of Matthews Correlation 
Coeffi cient (MCC) value. The nHLAPred line is marked with () 
and SVMHC line is marked with (). Almost for all MHC alleles 
our hybrid approach based method performed better as compared 
to SVMHC. (b) The plot illustrate the comparison of PREDEP and 
RANKPEP methods with our hybrid approach based method for 
HLA-A*0201 allele. (c) The plot demonstrates the compassion of 
our hybrid approach with polynomial method for HLA-A2.1 allele.
the fact that it is worthwhile to use prediction methods for 
identifying MHC binding peptides.
3.5b CTL epitopes: T cell epitopes generally have 
proteasomal cleavage sites at their carboxyl terminal 
(Ayyoub et al 2002; Goldberg et al 2002). The experimentally 
identifi ed four regions of the tumour-associated antigen 
PRAME were used to estimate the performance of the 
hybrid method in identifi cation of CTL epitopes (Kessler
et al 2001). The HLA-A*0201 binding regions were 
identifi ed by using combined approach at default cutoff 
score of 0.5. Thereafter, all proteasomal cleavage sites were 
predicted at various thresholds (1–10%). The MHC binders 
having the C terminal position coinciding with proteasomal 
cleavage site were predicted as potential CTL epitopes. 
The correctly identifi ed regions are shown in table 6. It is 
observed that at 7% threshold of the proteasomal fi lters 
(standard or immunoproteasome) the hybrid method was 
able to correctly identify the 75% regions of experimentally 
proven antigens by Kessler et al (2001).
3.6 Implementation of web server
We have developed a web server nHLAPred based on this 
hybrid approach, running on SUN server 420R under Solaris 
environment. The server is partitioned into two major parts, 
ComPred and ANNPred. ComPred allows to prediction of 
binders for 67 MHC alleles. The prediction for 30 MHC 
alleles is based on combined approach (ANN and QM) and 
prediction for the remaining 37 alleles is based on QM (17 
were generated in this study and 20 were obtained from 
literature). ANNPred allows the prediction of binders for 
only 30 alleles purely based on the artifi cial neural network. 
Both parts of the server use proteasomal matrices to predict 
the MHC binders possessing proteasomal cleavage site at
C terminal. The server can read input protein sequence in any 
of the standard formats as it uses the ReadSeq (developed by 
Dr Don Gilbert).
4. Discussion
The prime objective of this study is to assist biologists 
searching for potential vaccine candidates which can 
bind to a large number of MHC class I alleles and can 
also stimulate CTL cells. Presently available MHC class I 
binders prediction methods are based on motifs, quantitative 
matrices (Parker et al 1994 Rammensee et al 1999) neural 
networks (Brusic et al 1994; Adams and Koziol 1995) and 
structural information (Schueler-Furman et al 2000). In this 
study an attempt has been made to improve the accuracy of 
MHC class I restricted CTL epitopes prediction. Towards 
that, we have developed a quantitative matrix based method 
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Table 6. The analysis of nHLAPred on the four regions of PRAME protein (A:90-116; B:133-159; C:290-316; D:415-441) identifi ed as 
T cell epitopes by Kessler et al (2001). The MHC binders are predicted by using a cutoff score 0.5 and then predicted MHC binders are 
fi ltered by Proteasomal fi lters at varying thresholds.
Name of  fi lter Correctly predicted T cell epitopes in the PRAME protein at different thresholds ( out of 4)
3% 5% 7% 9% 10%
Standard Proteasome (SP) 1(A) 2(A) 2(A,D) 3(A,C,D) 3(A,C,D)
Immunoproteasome (IP) 2(A,D) 2(A,D) 3(A,C,D) 3(A,C,D) 3(A,C,D)
BOTH (SP or  IP) 2(A,D) 2(A,D) 3(A,C,D) 3(A,C,D) 3(A,C,D)
by generating new matrices for large number of MHC class 
I alleles. Further, an artifi cial neural network based method 
has been developed for alleles having suffi cient, number 
of experimentally proven binders. Finally, ANN- and 
QM-based methods were combined to develop a hybrid 
method, which integrated the merits of both the methods 
while minimizing their weaknesses. The performance of 
the method was evaluated using the jack-knife validation 
test. The performances of few alleles are also tested on 
an independent datasets wherever the independent data 
is available in literature. Both analysis demonstrated that 
method could predict the MHC binders with high accuracy.
The comparison of performance of different existing 
methods was very diffi cult as different criteria were used 
to assess the different algorithms and in most of the cases,
cross validation was not used. The predictive accuracy of 
hybrid approach was compared with the algorithms of most 
of available algorithms for MHC class I prediction. Our 
method performed better than all algorithms as shown in 
the results section, despite the fact that accuracy of earlier 
methods was not evaluated through jack-knife testing 
whereas the predictive accuracy of our method was obtained 
through jack-knife testing. The summary of performance 
of different methods when compared with our method is 
illustrated in table 5 and fi gure 3. This demonstrates that 
our method not only provides prediction for large number 
of alleles but also give more accurate prediction than the 
methods reported till date. The prime reason of improvement 
in the accuracy of prediction was due to larger dataset and 
combination of the two prediction methods. The output 
display formats of the server assists the users in locating the 
promiscuous MHC binding peptides in their query antigen 
sequence.
It is a well established fact that binding of a peptide 
to MHC molecule is a prerequisite to be recognized by 
T cell epitopes, but it is not necessary that all peptides 
bound to MHC molecule, will activate the T cells. Thus it 
is not necessary that all MHC binders are T cell epitopes. 
Recent studies have demonstrated that MHC binders 
having proteasome cleavage site at C terminal have higher 
potential to be T cell epitopes (Kessler et al 2001; Singh and 
Raghava 2003). In order to implement this observation, the 
prediction of proteasome cleavage site has been integrated 
in this method. The server allows the prediction of MHC 
binders possessing proteasomal cleavage site at C terminus, 
which are known as potential T cell epitopes. The methods 
for proteasome cleavage prediction are less accurate due 
to these three factors: (i) broad specifi city of proteasome 
as compared to MHC-peptide binding specifi city, (ii) 
availability of very limited amount of proteasome digested 
data and (iii) cleavage specifi city is not only dependent on the 
residues occurring at cleavage site but also on neighbouring 
residues. Thus, the prediction of only proteasome cleavage 
prediction can have more false positive results. Only a small 
fraction of the peptides produced by proteasome are passed 
through TAP transporter, binds to MHC and are recognized 
by T cell receptors. Therefore combing of proteasome 
cleavage with MHC binders and TAP binders prediction 
can lead to reduction in false positive results. The method is 
able to predict not only MHC binders but also CTL epitopes 
with high accuracy as shown in table 6. Thus, this strategy 
not only allows the users to predict the MHC binders but 
will also allow identifi cation of T cell epitopes, which are 
suitable candidates for subunit vaccine design. 
 Though the prediction accuracy of MHC (class I and 
class II) binder prediction methods has increased over the 
years, but still it is far away from perfection. Therefore, it 
is essential to experimentally validate the predicted MHC 
ligands before considering these as potential sub-unit 
vaccine candidates for peptide based vaccines. It would be 
advisable that one should test these predicted ligands using 
various in vitro screening methods (e.g. ELISPOT assay, 
T cell proliferation assay or MHC binding assay) to prove 
whether these contain naturally processed T cell epitopes 
or not.
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